|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
When not properly managed, hyperglycemia of hospitalized patients will result in poor patient outcomes. As a result, new patient treatment protocols such as Tight Glycemic Control (TGC) and Intensive Insulin Therapy (IIT) are becoming a standard of care in medical and surgical ICUs throughout the United States. Frequent and accurate bedside glucose testing is becoming imperative since clinicians are now using bedside results to titrate insulin dosage, rapidly achieve glucose target levels, and improve clinical outcomes. At the same time, potential adverse events such as serious hypoglycemia must be avoided. However, today’s bedside glucose meters may lack the accuracy, precision, freedom from interferences, and freedom from operator technique or errors dictated by these new protocols.
This educational series will examine the causes and consequences of glucose alterations in hospitalized patients, new bedside testing protocols and outcomes, and issues confounding the delivery of accurate, reliable bedside glucose testing. A new, patented technology glucose monitoring system that delivers a higher standard of care for bedside glucose testing will be summarized. Extensive data will be presented characterizing the performance of this technology at wide ranges of glucose, hematocrit, and oxygen; and interferences such as maltose, galactose, acetaminophen, and ascorbic acid.
|
|
|
|
|
|
|
This seminar will be beneficial to: |
|
|
|
|
|
|
POC Supervisors
Laboratory Managers
Nursing Directors
Diabetes Educators |
|
|
|
|
|
|
|
|
Jeff DuBois, Ph.D.
Vice President Medical & Scientific Affairs
Nova Biomedical, Waltham, MA |
|
|
|
|
Dr. DuBois has been with Nova Biomedical since 1999. Prior to joining Nova, he was on the faculty of the School of Medicine, Case Western Reserve University and served as Executive Director of Laboratory Services at University Hospitals Health System (UHHS), Cleveland, OH. At UHHS, he established a system-wide strategy for lab consolidation, standardization, and integration. He also implemented a POC Process Improvement Initiative involving Nova's Analyzers and Data Management System for remote connectivity of analyzers located in the ER, ICUs and ORs to the laboratory. He represented UHHS and Nova Biomedical on the NCCLS Automation Area Committee, initiated the NCCLS Committee on Point-of-Care Connectivity for which he served as Chairperson, and founded the Area Committee for POCT for which he served as its Chair for two years. Dr. DuBois is well published and a frequent speaker on connectivity, lab automation, lab consolidation, and point-of-care testing. He is a fellow of the Academy of Clinical Biochemists, a member of the American Association of Clinical Chemistry, American Diabetes Association, The Endocrinology Society, and the European Association for the Study of Diabetes. |
|
|
|
|
|
|
|
Terry Shirey, Ph.D.
Director of Medical Affairs
Nova Biomedical, Waltham, MA |
|
|
|
|
Dr. Shirey has developed a clinical studies program at Nova to investigate critical care testing in many clinical settings. He has published and lectured on the findings from these studies internationally to several professional societies including those specializing in intensive care medicine, clinical anesthesia, pediatric laboratory medicine, critical care, and clinical pathology. He received a Ph.D. in biochemistry from Colorado State University and has had subsequent postdoctoral training in molecular biology at Johns Hopkins University and in laboratory medicine at SUNY Buffalo. Dr. Shirey has also directed both hospital and reference laboratories. |
|
|
|
|
|
|
|
Becky Clarke, RN, BS
Executive Vice President
TELCOR, Lincoln, NE |
|
|
|
|
A founding partner of TELCOR and currently Executive Vice President for the Point of Care product line, Ms. Clarke has over thirty years of experience in healthcare and clinical information systems. Throughout her career in healthcare computing, she has played leading roles in design and deployment of commercially successful information systems for point-of-care testing data and interface management, radiology, laboratory, pharmacy, nursing, medication charting, many state-of-the-art system interfaces, as well as industry leading implementation processes. Her regulatory affairs involvement includes design of internal processes and procedures for GMP of regulated and non-regulated products. Ms. Clarke earned a B.S. in Health Arts from St. Francis College, Joliet, IL, and a diploma in nursing from Bryan Memorial Hospital, Lincoln, NE. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9:00AM-9:30AM |
|
|
|
Continental Breakfast |
|
|
|
|
|
|
|
9:30AM-10:00AM |
|
|
|
Overview of Glucose Alterations in Inpatient Settings: Causes and Consequences |
|
|
|
|
|
|
|
10:00AM-10:30AM |
|
|
|
New Glycemic Management Protocols, Requirements, and Outcomes |
|
|
|
|
|
|
|
10:30AM-11:00AM |
|
|
|
Analytical Obstacles to Effective Bedside Glucose Testing |
|
|
|
|
|
|
|
11:00AM-11:30PM |
|
|
|
A New Technology for Bedside Glucose Testing that Eliminates Errors from Hematocrit, Maltose, and Electrochemical Interferences |
|
11:30AM-12:00PM |
|
|
|
It's All in the Data |
|
|
|
|
|
|
|
12:00PM-1:00PM |
|
|
|
Buffet Lunch |
|
|
|
|
The seminar and course materials are provided at no charge. |
|
|
|
|
|
|
|
Nova is an approved as a Provider of educational programs in the clinical laboratory sciences by the following organizations: ASCLS, AACC, AACN
This seminar provides a choice of 1.5 contact hours of P.A.C.E, ACCENT, or AACN education credits.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
